Rolf Herter

Article

Interview mit Rolf Herter: "Oft geht es um Emotionen und weniger um Geld"

May 2021

Neuwagen beim Autohändler

Competition and Regulatory

Missbrauch relativer Marktmacht im Automobilvertrieb

Dr. Oliver Kaufmann  •   April 2021

Bücher

Dispute resolution and litigation

Bundesgericht heisst Revisionsgesuch gut, fällt Leitentscheid

Remo Busslinger  •   Maëve Romano  •   April 2021

Treppenhaus

Distribution law

Hast Du den Blick für das grosse Ganze?

Melanie Käser  •   Dr. Oliver Kaufmann  •   Dr. Christoph Wildhaber  •   April 2021

Medizinprodukte

Pharmaceuticals and healthcare

Medical devices: Swiss authorized representatives after the New Medical Device Regulation - What needs to be considered?

Matthias Stauffacher  •   Dr. Christoph Willi, LL.M.  •   April 2021

 VITH Lärm (Damian)AdobeStock_243571398 (2).jpeg

Article

VITH: Viel Lärm um nichts - wirklich?

Matthias Stauffacher  •   Dr. Christoph Willi, LL.M.  •   March 2021

Schweizer Bundeshaus

Competition and Regulatory

Relative Marktmacht: Drastische Ausweitung der Missbrauchskontrolle im Schweizer Kartellrecht

Dr. Oliver Kaufmann  •   March 2021

Fracht Flughafen

Pharmaceuticals and healthcare

New Medical Device Regulation: Is this now the end for parallel imports?

Matthias Stauffacher  •   Dr. Christoph Willi, LL.M.  •   March 2021

Hygienemasken

Pharmaceuticals and healthcare

Droht der Schweiz ein erneuter Versorgungsengpass?

Matthias Stauffacher  •   Dr. Christoph Willi, LL.M.  •   March 2021

Baum

Distribution law

Hat Dein Vertrieb System?

Melanie Käser  •   Dr. Oliver Kaufmann  •   Dr. Christoph Wildhaber  •   March 2021

Flaggen Schweiz und EU

Pharmaceuticals and healthcare

Drohendes Scheitern des institutionellen Rahmenvertrages: Auswirkungen für das schweizerische Gesundheitswesen

Matthias Stauffacher  •   Dr. Christoph Willi, LL.M.  •   March 2021

Beatmungsgeräte

Pharmaceuticals and healthcare

Medical devices: New challenges

Matthias Stauffacher  •   Dr. Christoph Willi, LL.M.  •   March 2021

Expertise

Dispute resolution and litigation

Conflicts are part of business life. Conditions in business and competition can often be challenging, so occasionally disputes with business partners, customers or competitors cannot be avoided. Even, for example, something as simple as a dispute with a neighbour over the pruning of a fruit tree in the garden can need mediation. Prudent and comprehensive advice is crucial right from the start.

Reagenzien

Pharmaceuticals and healthcare

Labormedizin: Kauf von Reagenzien im europäischen Ausland

Matthias Stauffacher  •   Dr. Christoph Willi, LL.M.  •   February 2021

Treppenhaus

IT legislation and data protection

Digital Transformation in Switzerland

Angelica Dünner-Graf  •   Melanie Käser  •   Matthias Stauffacher  •   February 2021

Spiegelung Kunstbild Reception

Distribution law

Sind Dienstleistungs-Konzepte geeignet für Franchising?

Melanie Käser  •   January 2021

Fotosession mit Aline Widmer

Article

Making-of Neuer Auftritt Streichenberg

Manuel Bader  •   Remo Busslinger  •   Melanie Käser  •   Dr. Oliver Kaufmann  •   January 2021

Matthias Stauffacher

IT legislation and data protection

Interview mit Matthias Stauffacher: Herausforderungen und Stolpersteine im Verwaltungsrecht

December 2020

Expertise

IT legislation and data protection

The digital revolution has brought numerous new developments to the world of work, from promising business ideas to alternative forms of work through to innovative services. Yet these changes call for competence in dealing with the challenges that have arisen as a result.

Expertise

Pharmaceuticals and healthcare

The health sector is facing increasingly complex legal and regulatory challenges. Any companies involved in life sciences and healthcare that want to build on their success need comprehensive support.

Expertise

M&A and Corporate Law

Companies face a variety of legal challenges every day. These call for specific expertise and a professional overview, but also collaboration built on trust.

Laborantin

Pharmaceuticals and healthcare

Analysenliste: Wie steht es um die Mitbestimmung bei den Labortarifen?

Matthias Stauffacher  •   Dr. Christoph Willi, LL.M.  •   November 2020